Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic LymphomakinasePositive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib
oleh: Nuran Katgı, Pınar Çimen, Murat Akyol, Pınar Gürsoy, Nurşin Agüloğlu
| Format: | Article |
|---|---|
| Diterbitkan: | AVES 2023-07-01 |
Deskripsi
No description available for this item.